Muscle dysmorphia: detection of the use-abuse of anabolic adrogenic steroids in a Spanish sample
DOI:
https://doi.org/10.20882/adicciones.853Keywords:
dismorfia muscular, esteroides, fisicoculturistas, muscle dysmorphia, steroids, bodybuildersAbstract
Debido a una distorsión en la imagen corporal, las personas que padecen Dismorfia Muscular se perciben menos musculosas de lo que son en realidad. Con el fin de aumentar su musculatura, algunas de estas personas hacen uso de hormonas cuya función principal es la del aumento del tamaño muscular. Por lo que el objetivo de este estudio es conocer la prevalencia del uso de hormonas en personas afectadas por Dismorfia Muscular. 562 hombres y 172 mujeres fisicoculturistas y levantadores de pesas, a los que se le administraron diferentes cuestionarios para conocer, primero si padecían el trastorno, y después en qué porcentaje usaban hormonas la muestra afectada. Para la creación de los modelos de regresión de la dismorfia muscular fueron empleadas las técnicas estadísticas de árboles de decisión (R = 0.78 y R2 = 0.62). Los resultados indican que casi un 50% de participantes, afectados por este trastorno, hacen uso de estas drogas. Due to a distortion in the body image, the people who suffer from muscle dysmorphia have the self-perception of being less muscular than they currently are. With the aim of increasing their muscular development, they resort to the use of AAS. The purpose of the present study is to know the prevalence of the use of AAS in a Spanish sample affected by muscle dysmorphia. 562 male and 172 female bodybuilders and weightlifters were provided with different questionnaires in order to know, firstly, if they suffered from this disorder and, secondly, the percentage of the participants affected who use these substances. Decision trees and regression was applied to create explanatory models for muscle dysmorphia (R = 0.78 and R2 = 0.62). The results show that almost 50% of the participants, male and female, affected by this disorder use this kind of drugs.References
Barrientos, N., Escoto, C., Bosques, L. E., Enríquez, J. y Juárez, C. S. (2014). Interiorización de ideales estéticos y preocupación corporal en hombres y mujeres usuarios de gimnasio. Revista Mexicana de Trastornos Alimentarios, 5, 29-38.
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, K., … Casaburi, R. (1997). Testosterone replacement increases fat-free mass and muscle size in hypogonodal men. Journal of Clinical Endocrinology & Metabolism, 82, 407-413. doi:10.1210/jc.82.2.407.
Bjørnebekk, A., Walhovd, K., Jørstad, M., Due-Tønnessen, P., Hullstein, I. y Fjell, A. (in press). Structural brain imaging of long term anabolic-androgenic steroid users and non-using weightlifters structural brain imaging of long term steroid use. Biological Psychiatry. Extraído de http://ac.els-cdn.com/S000632231632529X/1-s2.0-S000632231632529X-main.pdf?_tid=958212ec-c69e-11e6-af84-00000aacb360&acdnat=1482229689_fbd5fa4c3d445bd3f6a36319dcfaa21c.
Cole, J. C., Smith, R, Halford, J. C. y Wagstaff, G. F. (2003). A preliminary investigation into the relationship between anabolic androgenic steroids use and the symptoms of reverse anorexia in both current and ex users. Psychopharmacology, 166, 424-429.
Coomber, R., Pavlidis, A., Hanley, G., Wilde, M., Schmidt, W. y Redshaw, C. (2014). The supply of steroids and other performance and image enhancing drugs (PIEDs) in one English city: fakes, counterfeits, supplier trust, common beliefs and access. Performance Enhancement & Health, 3, 135–144.
De la Torre, R. (1995). Esteroides anabolizantes-androgénicos [Anabolic-androgenic steroids]. En I. D. d. Drogodependencia (Ed.), Drogas y deporte: farmacología del doping, pp. 53-63.
González-Martí, I. (2012). Elementos que integran el perfil de la persona afectada por Dismorfia Muscular (Vigorexia). Prevalencia del trastorno en fisicoculturistas y usuarios de la sala de musculación. (Tesis doctoral inédita). Universidad de Castilla-La Mancha, Cuenca.
González-Martí, I., Fernández, J. G., Contreras, O. R. y Mayville, S. B. (2012). Validation of a Spanish version of the Muscle Appearance Satisfaction Scale: Escala de Satisfacción Muscular. Body Image, 9, 517-523. doi:10.1016/j.bodyim.2012.05.002.
González-Martí, I., Fernández, J. G. y Contreras, O. R. (2012). Contribución para el criterio diagnóstico de la Dismorfia Muscular (Vigorexia) [Contribution to the diagnostic criteria for Muscle Dysmorphia (Bigorexia)]. Revista de Psicología del Deporte, 21, 351-358.
González-Martí, I., Fernández, J. G., Hernández-Martínez, A. y Contreras, O. R. (2014). Physical perceptions and self-concept in athletes with muscle dysmorphia symptoms. The Spanish Journal of Psychology, 17 (e43), 1-7. doi:10.1017/sjp.2014.45.
González-Martí, I. Hernández-Martínez, A., Fernández, J. G. y Contreras, O. R. (2016). Prevalence of muscle dysmorphia on female weightlifters and bodybuilders. Artículo presentado para su publicación.
Gruber, A. J., Pope, H. G., Borowiecki, J. y Cohane, G. (1999). The development of the somatomorphic matrix: a biaxial instrument for measuring body image in men and women. En T. S. Olds, J. Dolloman y K. I. Norton (Eds.), Kinanthropometry VI (pp. 217-232). Sydney: International Society for the Advancement of Kinanthropometry.
Hildebrandt, T., Schlundt, D., Langenbucher, J. y Chung, T. (2006). Presence of muscle dysmorphia symptomology among male weightlifters. Comprehensive Psychiatry, 47, 127-135. doi:10.1016/j.comppsych.2005.06.001.
Hildebrandt, T., Lai, J., Langenbucher, J., Schneider, M., Yehuda, R. y Pfaff, D. (2011). The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug and Alcohol Dependence, 114, 1-11. doi:10.1016/j.drugalcdep.2010.09.018.
Hildebrandt, T., Harty, S. y Langenbucher, J. W. (2012). Fitness supplements as a gateway substance for anabolic-androgenic steroid use. Psychology of Addictive Behaviors, 26(4), 955-962. doi:10.1016/j.drugalcdep.2010.09.018.
Jackson, A. y Pollock, M. (1978). Generalized equations for predicting body density in man. British Journal Nutrition, 40, 497-504.
Jampel, J. D., Murray, S. B., Griffiths, S. y Blashill, A. J. (2016). Self-perceived weight and anabolic steroids misuse among US adolescent boys. Journal of Adolescent Health, 58, 397-402. doi:10.1016/j.jadohealth.2015.10.003.
Kanayama, G., Pope, H. G., Cohane, G. y Hudson, J. I. (2003). Risk factors for anabolic androgenic steroid use among weightlifters: a case-control study. Drug and Alcohol Dependence, 71, 77-86. doi:10.1016/S0376-8716(03)00069-3.
Kanayama, G., Barry, S., Hudson, J. I. y Pope Jr., H. G. (2006). Body image and attitudes toward male role in anabolic-androgenic steroid users. American Journal of Psychiatry, 163, 697-703. doi:10.1176/appi.ajp.163.4.697.
Kanayama, G., Hudson, J. I. y Pope Jr., H. G. (2009). Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug and Alcohol Dependence, 102, 1030-137. doi:10.1016/j.drugalcdep.2009.02.008.
Kouri, E. M., Pope, H. G., Katz, D. L. y Oliva, P. (1995). Fat-Free Mass Index in users and nonusers of anabolic-androgenic steroids. Clinical Journal of Sports Medicine, 5, 223-228. doi:10.1097/00042752-199510000-00003.
Kyle, U. G., Schutz, Y., Dupertuis, Y. M. y Pichard, C. (2003). Body composition interpretation: contributions of the fat-free mass index and the body fat mass index. Nutrition, 19, 597-604. doi:10.1016/S0899-9007(03)00061-3.
Murray, S. B., Griffiths, S., Mond, J. M., Kean, J. y Blashill, A. J. (En prensa). Anabolic steroid use and body image psychopathology in men: delineating between appearance- versus performance-driven motivations. Drug and Alcohol Dependence. doi:10.1016/j.drugalcdep.2016.06.008.
Olivardia, R., Pope, H. G. y Hudson, J. (2000). Muscle dysmorphia in male weightlifters: a case-control study. American Journal of Psychiatry, 157, 1291-1296. doi:10.1176/appi.ajp.157.8.1291.
Pipet, S., Halpern, R., Woody, G. E. y Szobot, C. (2014). Association between AAS use, muscle dysmorphia and illicit drug use among gym frequenters. Drug and Alcohol Dependence, 140, e178. doi:10.1016/j.drugalcdep.2014.02.499.
Pope, H. G., Katz, D. & Hudson, J. (1993). Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Comprehensive Psychiatry, 34, 406-409.
Pope, H. G., Gruber, A., Choi, P., Olivardia, R. y Phillips, K. (1997). Muscle dysmorphia. An underrecognized form of Body Dysmorphic Disorder. Psychosomatics, 38, 548-557. doi:10.1016/S0033-3182(97)71400-2.
Pope, H. G., Phillips, K. y Olivardia, R. (2000). The Adonis Complex. How to identify, treat and prevent body obsession in men and boys. New York: A Touchstone Book.
Pope, H. G., Kanayama, G., Ionescu-Pioggia, M. y Hudson, J. I. (2004). Anabolic steroid users´ attitudes towards physicians. Addiction, 99, 1189-1194. doi:10.1111/j.1360-0443.2004.00781.x.
Pope, C. G., Pope, H. G., Menard, W., Fay, C., Olivardia, R. y Phillips, K. (2005). Clinical features of muscle dysmorphia among males with dysmorphic disorder. Body Image, 2, 395-399. doi:10.1016/j.bodyim.2005.09.001.
Pope, H. G., Kanayama, G. y Hudson, J. I. (2012). Risk for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biological Psychiatry, 71, 254-261. doi:10.1016/j.biopsych.2011.06.024.
Pope, H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I. y Baggish, A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current estimates. American Journal on Addiction 23, 371-373. doi:10.1111/j.1521-0391.2013.12118.x.
Rocha, M., Aguiar, F. y Ramos, H. (2014). O uso de esteroides androgénicos anabolizantes e outros suplementos ergogénicos – uma epidemia silenciosa. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 9, 98-105. doi:10.1016/j.rpedm.2014.09.002
Rodríguez-Testal, J. F., Senín-Calderon, C. y Perona-Garcelán, S. (2014). From DSM-IV-TR to DSM-5: Analysis of some changes. International Journal of Clinical and Health Psychology, 14, 221-231. doi:10.1016/j.ijchp.2014.05.002.
Rohman, L. (2009). The relationship between anabolic androgenic steroids and muscle dysmorphia: a review. Eating Disorder, 17, 187-199. doi:10.1080/10640260902848477.
Sokolova, M. V., González-Martí, I., Contreras, O. R. y Fernández, J. G. (2013). A case study of muscle dysmorphia disorder diagnostics. Expert Systems with Applications, 40, 4226-4231. doi:10.1016/j.eswa.2013.01.023.
Thiblin, I., Garmo, H., Garle, M., Holmberg, L., Byberg, L., Michaëlsson, K.,… Gedeborg, R. (2015). Anabolic steroids and cardiovascular risk: a national population-based cohort study. Drug and Alcohol Dependence, 152, 87-92. doi:10.1016/j.drugalcdep.2015.04.013.
Van Hout, M. C. y Kean, J. (2015). An exploratory study of image and performance enhancement drug use in a male British South Asian community. International Journal of Drug Policy, 26, 860–867. doi:10.1016/j.drugpo.2015.03.002.
